Bults Marloes, van Leersum Catharina Margaretha, Olthuis Theodorus Johannes Josef, Bekhuis Robin Enya Marije, den Ouden Marjolein Elisabeth Maria
Technology, Health & Care Research Group, Saxion University of Applied Sciences, Enschede, Netherlands.
Science, Technology, and Policy Studies, Faculty of Behavioural, Management and Social Sciences, University of Twente, Enschede, Netherlands.
JMIR Diabetes. 2023 Jan 24;8:e41076. doi: 10.2196/41076.
Mobile health apps are promising tools to help patients with type 2 diabetes mellitus (T2DM) improve their health status and thereby achieve diabetes control and self-management. Although there is a wide array of mobile health apps for T2DM available at present, apps are not yet integrated into routine diabetes care. Acceptability and acceptance among patients with T2DM is a major challenge and prerequisite for the successful implementation of apps in diabetes care.
This study provides an in-depth understanding of the perceptions of patients with T2DM before use (acceptability) and after use (acceptance) regarding 4 different mobile health apps for diabetes control and self-management.
A descriptive qualitative research design was used in this study. Participants could choose 1 of the 4 selected apps for diabetes control and self-management (ie, Clear.bio in combination with FreeStyle Libre, mySugr, MiGuide, and Selfcare). The selection was based on a systematic analysis of the criteria for (functional) requirements regarding monitoring, data collection, provision of information, coaching, privacy, and security. To explore acceptability, 25 semistructured in-depth interviews were conducted with patients with T2DM before use. This was followed by 4 focus groups to discuss the acceptance after use. The study had a citizen science approach, that is, patients with T2DM collaborated with researchers as coresearchers. All coresearchers actively participated in the preparation of the study, data collection, and data analysis. Data were collected between April and September 2021. Thematic analysis was conducted using a deductive approach using AtlasTi9.
In total, 25 coresearchers with T2DM participated in this study. Of them, 12 coresearchers tested Clear, 5 MiGuide, 4 mySugr, and 4 Selfcare. All coresearchers participated in semistructured interviews, and 18 of them attended focus groups. Personal health was the main driver of app use. Most coresearchers were convinced that a healthy lifestyle would improve blood glucose levels. Although most coresearchers did not expect that they need to put much effort into using the apps, the additional effort to familiarize themselves with the app use was experienced as quite high. None of the coresearchers had a health care professional who provided suggestions on using the apps. Reimbursement from insurance companies and the acceptance of apps for diabetes control and self-management by the health care system were mentioned as important facilitating conditions.
The research showed that mobile health apps provide support for diabetes control and self-management in patients with T2DM. Integrating app use in care as usual and guidelines for health care professionals are recommended. Future research is needed on how to increase the implementation of mobile health apps in current care pathways. In addition, health care professionals need to improve their digital skills, and lifelong learning is recommended.
移动健康应用程序是很有前景的工具,可帮助2型糖尿病(T2DM)患者改善健康状况,从而实现糖尿病控制和自我管理。尽管目前有大量针对T2DM的移动健康应用程序,但这些应用程序尚未融入常规糖尿病护理中。T2DM患者对其的可接受性和接受度是在糖尿病护理中成功应用这些应用程序的主要挑战和前提条件。
本研究深入了解T2DM患者在使用4种不同的用于糖尿病控制和自我管理的移动健康应用程序之前(可接受性)和之后(接受度)的看法。
本研究采用描述性定性研究设计。参与者可以从4种选定的用于糖尿病控制和自我管理的应用程序中选择1种(即Clear.bio与FreeStyle Libre结合、mySugr、MiGuide和Selfcare)。选择基于对监测、数据收集、信息提供、指导、隐私和安全方面(功能)要求标准的系统分析。为了探索可接受性,在使用前对25名T2DM患者进行了半结构化深度访谈。随后进行了4个焦点小组讨论使用后的接受度。该研究采用公民科学方法,即T2DM患者作为共同研究者与研究人员合作。所有共同研究者都积极参与了研究准备、数据收集和数据分析。数据于2021年4月至9月收集。使用AtlasTi9采用演绎法进行主题分析。
共有25名患有T2DM的共同研究者参与了本研究。其中,12名共同研究者测试了Clear,5名测试了MiGuide,4名测试了mySugr,4名测试了Selfcare。所有共同研究者都参与了半结构化访谈,其中18人参加了焦点小组。个人健康是应用程序使用的主要驱动力。大多数共同研究者确信健康的生活方式会改善血糖水平。尽管大多数共同研究者预计自己在使用应用程序时不需要付出太多努力,但他们体验到熟悉应用程序使用的额外努力相当大。没有一名共同研究者有医疗保健专业人员就使用应用程序提供建议。保险公司的报销以及医疗保健系统对用于糖尿病控制和自我管理的应用程序的接受被提及为重要的促进条件。
研究表明,移动健康应用程序为T2DM患者的糖尿病控制和自我管理提供了支持。建议将应用程序的使用融入常规护理以及为医疗保健专业人员制定指导方针。未来需要研究如何在当前护理路径中增加移动健康应用程序的实施。此外,医疗保健专业人员需要提高他们的数字技能,建议进行终身学习。